wy 50324 has been researched along with sb 206553 in 1 studies
| Studies (wy 50324) | Trials (wy 50324) | Recent Studies (post-2010) (wy 50324) | Studies (sb 206553) | Trials (sb 206553) | Recent Studies (post-2010) (sb 206553) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 102 | 0 | 28 |
| Protein | Taxonomy | wy 50324 (IC50) | sb 206553 (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.05 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0094 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, LA; Djali, S; Galandak, J | 1 |
1 other study(ies) available for wy 50324 and sb 206553
| Article | Year |
|---|---|
Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.
Topics: Amino Acids; Animals; Brain Ischemia; Fluorobenzenes; Hippocampus; In Vitro Techniques; Indoles; Ligands; Male; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |